Omeros Corporation

(OMER) Trade

By |

Profile

Omeros Corp is a United States based biopharmaceutical company. Its goal is to research, develop, and commercialize small-molecule and protein therapeutics targeting inflammation, coagulopathies, and disorders of the central nervous system. The company owns Omidria (phenylephrine and ketorolac injection), approved by the U.S. Food and Drug Administration and launched in the U.S. for use during cataract surgery and intraocular lens replacement. Its product pipeline is focused on complement-associated thrombotic microangiopathies; complement-mediated glomerulonephropathies; Huntington's disease and cognitive impairment; and addictive and compulsive disorders.

Contact Information

Website: www.omeros.com
Main Phone: +1 206 676-5000
Address: 201 Elliott Avenue West
State: WA
City / Town: Seattle
Country: USA
Postal Code: 98119

Issuer Information

Exchange: NSD
CEO: Gregory A. Demopulos
Employees: 173
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 14.35 $ -0.12 (-0.83%)
Last Price 14.35 Change $ -0.12 Change % -0.83 Tick N/A
Bid 13.80 Bid Size 200.00 Ask 14.90 Ask Size 100.00
Open 14.43 High 14.80 Low 13.94 Prev Close 14.47
Last Trade Volume 663,431 52 Wk Hi 27.00 52 Wk Low 8.36
Market Cap 703.3 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 49,009,310.00 EPS (TTM) -2.47 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 5 17
Number of Buys 3 12
Number of Sells 2 5
Net Activity 5000 166005
Last 10 Buys Shares
Peter A. Demopulos 1,000
Peter A. Demopulos 1,000
Ray Aspiri 1,000
Peter A. Demopulos 1,000
Arnold C. Hanish 1,000
Peter A. Demopulos 1,000
Peter A. Demopulos 1,000
Peter A. Demopulos 1,000
Last 10 Sell Shares
Michael A. Jacobsen 1,000
Michael A. Jacobsen 1,000
Marcia S. Kelbon 1,000
Michael A. Jacobsen 1,000
Michael A. Jacobsen 1,000
Michael A. Jacobsen 1,000
Michael A. Jacobsen 1,000
Michael A. Jacobsen 1,000
Thomas J. Cable 1,000
Thomas J. Cable 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 34 34 34 34
Low Target Price Estimate 20 20 20 20
Mean Target Price Estimate 26.33 26.33 26.33 26.33
Standard Deviation 7.09 7.09 7.09 7.09
Date of Most Recent Estimate 05/17/18 05/17/18 05/17/18 05/17/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 3
Moderate Buy 0 0 0 0
Hold 2 2 2 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2 2 2 1.5